Asset Details
Do you wish to reserve the book?
Intelligent MDT treatment decision making for stage III NSCLC using dual level embedding and three level explanation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Intelligent MDT treatment decision making for stage III NSCLC using dual level embedding and three level explanation
Do you wish to request the book?
Intelligent MDT treatment decision making for stage III NSCLC using dual level embedding and three level explanation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Intelligent MDT treatment decision making for stage III NSCLC using dual level embedding and three level explanation
2026
Overview
Stage III non-small cell lung cancer (NSCLC) presents complex challenges in treatment decisions due to extensive disease characteristics and patient heterogeneity. Multidisciplinary teams (MDT) offer personalized treatments by integrating diverse expertise. However, resource and time constraints limit MDT practicality in healthcare. Addressing this, we propose an interpretable approach for intelligent MDT treatment recommendations. Our approach focuses on enhancing clinical text representation and the interpretability of recommendations. Using a dual-level embedding technique, the local and global textual information can be captured. By delving into intricate factors at word, phrase, and sentence levels, we explain treatment recommendations for heterogeneous patients. Specially, attention flow is employed to consider the relationship between attentions across multiple layers, and attention mechanisms screen out important words and sentences. Our method achieves over 85% across accuracy, precision, recall, and F1 score in stage III NSCLC treatment recommendations. Furthermore, we assess the association between our proposed model and patient survival outcomes by analyzing patients who did not undergo MDT consultation. The results demonstrate that patients receiving model-concordant treatments exhibited significantly higher survival rates at 1, 3, and 5 years compared to those receiving model-nonconcordant treatments. Moreover, Kaplan-Meier survival curves confirm the improvement in survival outcomes associated with model-concordant treatments. Additionally, ablation analysis validates the rationality of the model structure.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 692/308
/ 692/699
/ Accuracy
/ Carcinoma, Non-Small-Cell Lung - mortality
/ Carcinoma, Non-Small-Cell Lung - pathology
/ Carcinoma, Non-Small-Cell Lung - therapy
/ Clinical Decision-Making - methods
/ Clinical practice guidelines
/ Humanities and Social Sciences
/ Humans
/ Intelligent treatment decision-making
/ Non-small cell lung carcinoma
/ Patients
/ Science
/ Stage III non-small cell lung cancer
/ Survival
